The ovarian cancer market is witnessing transformative shifts fueled by advancements in diagnostic methods, increasing prevalence rates, and heightened awareness regarding gynecological health. Ovarian cancer, a malignancy that arises in the ovaries, is notorious for its late detection and high mortality rates. As one of the most lethal gynecologic cancers, it demands urgent innovation in...